Literature DB >> 18208534

Cryptogenic stroke: time to determine aetiology.

F Guercini1, M Acciarresi, G Agnelli, M Paciaroni.   

Abstract

Strokes that remain without a definite cause even after extensive work-up are classified as cryptogenic. These constitute about 30-40% of all strokes. Stroke aetiology may remain undetermined for the following reasons: (i) the cause of stroke is transitory or reversible and the diagnostic work-out is not therefore performed at the appropriate time; (ii) all known causes of stroke are not fully investigated; (iii) some causes of stroke remain unknown. Recent studies have challenged the previous view that cryptogenic stroke is a relatively benign cerebrovascular event, and have shown that cryptogenic stroke is associated with a higher rate of recurrence and adverse outcome at long-term follow-up. The determination of stroke aetiology is a valuable procedure to avoid the risk of stroke recurrence, especially in young patients. In this review, we discuss new evidence on the aetiology of cryptogenic stroke, specifically focusing on patients with patent foramen ovale and atheroma of the aortic arch.

Entities:  

Mesh:

Year:  2008        PMID: 18208534     DOI: 10.1111/j.1538-7836.2008.02903.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  26 in total

1.  RNA expression profiles from blood for the diagnosis of stroke and its causes.

Authors:  Frank R Sharp; Glen C Jickling; Boryana Stamova; Yingfang Tian; Xinhua Zhan; Bradley P Ander; Christopher Cox; Beth Kuczynski; Dazhi Liu
Journal:  J Child Neurol       Date:  2011-06-02       Impact factor: 1.987

2.  Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-13       Impact factor: 8.311

3.  96 hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack.

Authors:  Giorgia Manina; Giancarlo Agnelli; Cecilia Becattini; Gianluca Zingarini; Maurizio Paciaroni
Journal:  Intern Emerg Med       Date:  2012-01-17       Impact factor: 3.397

4.  Cryptogenic stroke-the appropriate diagnostic evaluation.

Authors:  Hardik Amin; David M Greer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

Review 5.  Neurogenesis in Stroke Recovery.

Authors:  Seong-Ho Koh; Hyun-Hee Park
Journal:  Transl Stroke Res       Date:  2016-03-18       Impact factor: 6.829

6.  Auditing the frequency and the clinical and economic impact of testing for Fabry disease in patients under the age of 70 with a stroke admitted to Saint Vincent's University Hospital over a 6-month period.

Authors:  J Lambe; I Noone; R Lonergan; N Tubridy
Journal:  Ir J Med Sci       Date:  2017-05-03       Impact factor: 1.568

7.  Molecular MRI of Thrombosis.

Authors:  Katie L Ciesienski; Peter Caravan
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010

8.  In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.

Authors:  Ilknur Ay; Francesco Blasi; Tyson A Rietz; Nicholas J Rotile; Sreekanth Kura; Anna Liisa Brownell; Helen Day; Bruno L Oliveira; Richard J Looby; Peter Caravan
Journal:  Circ Cardiovasc Imaging       Date:  2014-04-28       Impact factor: 7.792

9.  Fibrin-targeted PET probes for the detection of thrombi.

Authors:  Katie L Ciesienski; Yan Yang; Ilknur Ay; Daniel B Chonde; Galen S Loving; Tyson A Rietz; Ciprian Catana; Peter Caravan
Journal:  Mol Pharm       Date:  2013-01-30       Impact factor: 4.939

10.  [Atrial fibrillation. New aspects for diagnosis and follow-up].

Authors:  C Eitel; G Hindricks; C Piorkowski
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.